Literature DB >> 11683577

T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy.

A M Dyrhol-Riise1, M Ohlsson, K Skarstein, S J Nygaard, J Olofsson, R Jonsson, B Asjö.   

Abstract

T cell turnover was studied in situ in tonsillar lymphoid tissue (LT) from HIV-1-infected individuals during 48 weeks of highly active antiretroviral therapy (HAART) and compared to that of HIV-1-negative controls. Prior to therapy, CD4 cell proliferation (%CD4+ Ki67+) and apoptosis (%CD4+ TUNEL+) were increased in HIV-1-infected LT and both parameters correlated with tonsillar viral load. CD8 cell proliferation (%CD8+ Ki67+) was increased 4- to 10-fold, mainly in the germinal centers. Apoptotic CD8+ T cell levels (%CD8+ TUNEL+) were raised preferentially in the tonsillar T cell zone. The frequency of CD8+ Ki67+ and CD8+ TUNEL+ T cells correlated with tonsillar viral load and with the fraction of CD8(+) T cells expressing activation markers. During HAART, CD4 cell turnover normalized while CD8 cell turnover was dramatically reduced. However, low level viral replication concomitant with slightly elevated levels of CD8 cell turnover indicated a persistent cellular immune response in LT. In conclusion, enhanced T cell turnover may reflect effector cells related to HIV-1 infection. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683577     DOI: 10.1006/clim.2001.5102

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

Authors:  Jean-Philippe Herbeuval; Jakob Nilsson; Adriano Boasso; Andrew W Hardy; Michael J Kruhlak; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Jan Andersson; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 2.  Studies of HIV-associated immune responses in lymphoid compartments.

Authors:  Susanna Grundström; Jan Andersson
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

3.  Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.

Authors:  Olga Millán; Mercè Brunet; Jaume Martorell; Felipe García; Elena Vidal; Isabel Rojo; Montserrat Plana; Teresa Gallart; Tomas Pumarola; Jose M Miró; Jose M Gatell
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Authors:  Marc K Hellerstein; Rebecca A Hoh; Mary Beth Hanley; Denise Cesar; Daniel Lee; Richard A Neese; Joseph M McCune
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha.

Authors:  Andrew W Hardy; David R Graham; Gene M Shearer; Jean-Philippe Herbeuval
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

6.  HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.

Authors:  Jean-Philippe Herbeuval; Jakob Nilsson; Adriano Boasso; Andrew W Hardy; Monica Vaccari; Valentina Cecchinato; Valerio Valeri; Genoveffa Franchini; Jan Andersson; Gene M Shearer
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

7.  CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV.

Authors:  Dorothy E Lewis; Kimber L Gross; Martine M Diez; Maria L Martinez; Helen N Lukefahr; Claudia A Kozinetz; Roberto C Arduino
Journal:  J Transl Med       Date:  2007-01-30       Impact factor: 5.531

Review 8.  Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.

Authors:  Adriano Boasso
Journal:  Scientifica (Cairo)       Date:  2013-12-22

9.  Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients.

Authors:  Jun-Nan Lv; Jia-Qi Li; Ying-Bin Cui; Yuan-Yuan Ren; Ya-Jing Fu; Yong-Jun Jiang; Hong Shang; Zi-Ning Zhang
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.